Jacobs School faculty member Thomas D. Grant is seeking to transform the way in which scientists study proteins in their natural environment. Photo: Sandra Kicman Published September 22, 2025 UB researcher Thomas Grant has been awarded a $2.18 million …

Lilly partnership provides infrastructure to advance platform-discovered therapies targeting neurodegeneration SAN DIEGO, CA, UNITED STATES, September 22, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio, a biotechnology company developing therapies that …

The Begbies say they don't want Sanfilippo Syndrome to take away happy moments from their daughter, but new regulations have made it hard to receive proper care. KNOXVILLE, Tenn. — Bryan and Blair Begbie said all they want for Rowan — their youngest …

New research published today on World Alzheimer's Day brings encouraging news for millions of Britons worried about dementia. Scientists have found that simple lifestyle changes could cut your risk of developing the condition by as much as 45 per cent. …

France was once a pioneer of Alzheimer's care, but as the number of sufferers continues to rise and budgets are cut, the country is now struggling to tackle what is one of the world's most pressing public health crises. Approximately 1.4 million …

Alzheimer’s in women remains dangerously underdiagnosed despite major breakthroughs in research and care, experts have told The National. While science is transforming how the disease is managed, caregiver support and sex-specific diagnosis are still …

Alzheimer's disease is the most common type of dementia and occurs when the brain stops functioning properly. Alzheimer's disease is typically associated with the elderly, but it can also affect younger people. In recent years, symptoms have been …

Lundbeck and Otsuka America Pharmaceutical announced Otsuka has received a Complete Response Letter (CRL) from FDA regarding the supplemental New Drug Application (sNDA) for use of Rexulti in combination with sertraline as a treatment of adults with post- …

Billions of dollars have been spent trying to find a treatment for Alzheimer's disease over the decades, but those efforts have stubbornly fallen short -- at least until recently. But the expensive treatments are only modestly effective, and work only …